A detailed history of L2 Asset Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, L2 Asset Management, LLC holds 5,817 shares of BSX stock, worth $517,422. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,817
Previous 5,616 3.58%
Holding current value
$517,422
Previous $432,000 12.73%
% of portfolio
0.14%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $14,664 - $16,884
201 Added 3.58%
5,817 $487,000
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $35,550 - $41,030
528 Added 10.38%
5,616 $432,000
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $20,563 - $24,497
357 Added 7.55%
5,088 $348,000
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $217,858 - $258,930
4,479 Added 1777.38%
4,731 $273,000
Q3 2023

Nov 08, 2023

BUY
$50.19 - $54.68 $12,647 - $13,779
252 New
252 $13,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track L2 Asset Management, LLC Portfolio

Follow L2 Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.